一种潜在变量模型,用于评估癌症驱动突变之间的相互排他性和同时发生
Ahmed Shuaibi1,2, Uthsav Chitra1, Benjamin J Raphael1
1Department of Computer Science, Princeton University.
bioRxiv : the preprint server for biology
|May 7, 2024
概括
在癌症中识别驱动突变是具有挑战性的. 一个新的算法DIALECT准确地将驾驶员突变与乘客突变区分开来,揭示了真正的功能依赖,如相互排他性和共同发生.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 癌症研究 癌症研究
背景情况:
- 了解体质突变对于癌症基因组学至关重要.
- 驾驶员突变,与乘客突变不同,驱动癌症的发展.
- 现有的方法难以区分驾驶员和乘客突变,导致不准确的依赖性分析.
研究的目的:
- 开发一个算法,准确地识别驱动器突变之间的功能依赖.
- 在癌症基因组学数据中,将驾驶员突变与乘客突变分开.
- 改善推断驱动突变之间的相互排他性和并发模式.
主要方法:
- 介绍了DIALECT,一种用于识别驱动器突变之间的依赖关系的算法.
- 开发了一个潜在的可变混合模型来区分驾驶员和乘客的突变.
- 使用预期最大化 (EM) 算法进行参数估计.
主要成果:
- 方言准确地推断出驱动器突变之间的相互排他性和共发生.
- 与模拟数据上的现有方法相比,证明了更高的性能.
- 在癌症基因组图谱 (TCGA) 中对五种癌症类型的体质突变数据的验证结果.
结论:
- 方言有效地识别了驱动器突变之间的功能依赖.
- 该算法通过区分突变类型来克服基因水平分析的局限性.
- 方言增强了发现新的癌症驱动突变相互作用的发现.
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mutation, Gene Flow, and Genetic Drift
58.3K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
58.3K


